Clinical Trials List
Protocol NumberMOST 111-2314-B-182A-042-
2022-10-01 - 2025-07-31
Phase II
Recruiting1
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Gigin Lin Division of Radiology
- Ming-Chung Kao Division of Hematology & Oncology
- 林宇旌 Division of Radiology
- 林潔 Division of Nuclear Medicine
- Shu-Hang Ag Division of Radiology
- 高小雯 Division of Hematology & Oncology
- Hung Chang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
16 participants
-
Global
16 participants
